<DOC>
	<DOCNO>NCT00801541</DOCNO>
	<brief_summary>To study identify sequence alteration occur chorioretinal interface progression AMD `` dry '' AMD sight-threatening chorioretinal neovascularization ( CNV ) .</brief_summary>
	<brief_title>Characterization Early Markers Choroidal Neovascularization</brief_title>
	<detailed_description>The primary statistical objective study identify sequence alteration occur chorioretinal interface progression AMD risk `` dry '' AMD sight-threatening chorioretinal neovascularization ( CNV ) ( wet AMD ) . Different image method use simultaneously regular interval order characterize marker predictor conversion sight-threatening CNV : CNV ( classic occult ) position CNV within 2500 µm ( ~1.7 disc diameter ) foveal center , evidence fluorescein angiography . This institutional , prospective , observation study perform fellow eye patient evidence `` wet '' AMD eye . Therefore , patient evidence exudative ( `` wet '' ) AMD one eye ( non-study eye ) non-exudative ( `` dry '' ) AMD fellow eye ( study eye ) risk progressive exudation `` wet '' CNV . Patients exit study time develop sight-threatening CNV study eye treat discretion physician .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<criteria>Written inform consent Age 50 year Any race sex Clinical diagnosis exudative AM ; D one eye ( nonstud eye ) presence follow characteristic second eye ( study eye , eye treat ) : At least 5 intermediate ( &gt; 63 µm ) large soft drusen AND/OR Confluent drusen within 3000 µm fovea center Hyperpigmentation History medical condition would preclude schedule study visit History ophthalmic disease study eye AMD Clinical sign myopic retinopathy , refraction high 8 diopter power . Intraocular surgery study eye within 60 day prior enrollement Evidence past present CNV study eye</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>AMD</keyword>
</DOC>